DENISE DOLAN: Open Payments
NPI 1669533147 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$97 in 7 payments from 5 companies in 2025. Trend: 2023 $154 · 2024 $82 · 2025 $97
Food & beverage: $97
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $35 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Sage Therapeutics, LLC | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $8 |
Products named: Veozah, MYFEMBREE, ZURZUVAE, Qelbree.
Industry payments across NJ — which companies pay providers there.
